LI
AGTC

Leap Investments’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Leap Investments’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-13,200
Closed -$43K – 622
2020
Q1 		$43K Buy
+13,200
New +$69.6K 0.06% 332

Other funds holding AGTC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Leap Investments's AGTC Position: Q2 2020 in Review

Leap Investments sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2020, closing a stake of 13,200 shares — an estimated $43K sold.

Leap Investments first reported a position in AGTC in Q1 2020 and held it in 1 quarter. The position peaked at $43K in Q1 2020. 65 funds tracked by Wall St. Rank hold AGTC as of Q2 2020.

  • Leap Investments reported no remaining Applied Genetic Technologies Corporation position as of Q2 2020 after selling out during the quarter.
  • Leap Investments sold 13,200 Applied Genetic Technologies Corporation shares in Q2 2020, an estimated $43K.
  • Leap Investments first reported a position in Applied Genetic Technologies Corporation in Q1 2020 and held it in 1 quarter.
  • Leap Investments's Applied Genetic Technologies Corporation position peaked at $43K in Q1 2020.
  • 65 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.